Publication | Closed Access

Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-κB mediated epithelial–mesenchymal transition and stemness

Tumor BiologyLung InflammationMedicineEpithelial–mesenchymal TransitionImmunologyCancer Cell BiologyGinsenoside Rg3Cancer BiologyCancer TreatmentOncologyCell BiologyLung CancerCancer ResearchCancer Growth